(RTTNews) – Eli Lilly and Co.’s (LLY) tirzepatide showed an additional 21.1% weight loss after 12 weeks of intensive lifestyle intervention, for a total mean weight loss of 26.6% from study entry over 84 weeks.
Lilly’s Tirzepatide Shows Addl 21.1% Weight Loss After 12 Weeks Of Intensive Lifestyle Intervention
By 
Add A Comment